Hydrus Microstent

Description of Procedure:

Prior to the date of surgery, the risks, benefits, and alternatives of the planned procedure were discussed with the patient, and informed consent was obtained. The patient was identified in the preoperative area by the attending physician, and the operative eye was marked. The patient was taken to the operative suite and given IV sedation and topical ocular anesthesia. The operative eye was prepped and draped in the usual sterile ophthalmic fashion. A lid speculum was inserted.

The patient’s head was rotated 35 degrees away from the surgeon, and the operating microscope was rotated 35 degrees toward the surgeon. A paracentesis was made into clear cornea. Epi-Shugarcaine and viscoelastic were injected into the anterior chamber. Additional viscoelastic was injected onto the cornea to serve as a coupling agent. A direct gonioprism was used to visualize the nasal angle. The trabecular meshwork was easily identified. The Hydrus Microstent was primed then advanced into the trabecular meshwork. A Sinsky hook was used to move the stent into final position with a small segment visible in the anterior chamber.

The patient’s head and the operating microscope were rotated back into neutral positions. All remaining viscoelastic was irrigated using balanced salt solution. The corneal incisions were hydrated with balanced salt solution then inspected with a Weck-cel sponge and found to be watertight with good intraocular pressure by finger tension. The speculum and drapes were removed, and antibiotic-steroid drops were placed into the eye. The patient was then transported to the postoperative care unit in good condition.